重编程
癌症研究
肝移植
心理压抑
肝病
肝衰竭
功能(生物学)
化学
下调和上调
巨噬细胞
细胞生物学
医学
肝功能
肝癌
移植
药理学
肝损伤
生物
肝损伤
调制(音乐)
药品
作者
Panyu Chen,Bingyuan Huang,Wentao Chen,Xiao Lin,Changjie Yang,Chen Wang,Wenxi Su,Zhaokai Zeng,Yunyun Ren,Shijie Fan,Yun Song,Rong Fu,Yixuan Xu,Xiaosong Chen,Xiaogang Xiang,Guangming Li,Kaixian Chen,Xiong Ma,Yugang Wang,Yuanyuan Zhang
标识
DOI:10.1038/s41467-026-78245-x
摘要
Acute-on-chronic liver failure is a severe syndrome with high short-term mortality, and current treatments are limited to liver transplantation and supportive care. Here we show that EP300 inhibition alleviates acute-on-chronic liver failure by targeting scar-associated macrophages, a subset that proliferates during disease progression and whose impaired antibacterial function is linked to poor prognosis. EP300 inhibition enhances the antibacterial activity of scar-associated macrophages through transcriptional repression of ACOD1. ACOD1 expression is induced in scar-associated macrophages during acute-on-chronic liver failure, and its loss mitigates hepatic destruction and prolongs survival in male mice with acute-on-chronic liver failure by enhancing the phagocytic function of scar-associated macrophages. These findings suggest that EP300 inhibition alleviates acute-on-chronic liver failure through ACOD1-dependent reprogramming of scar-associated macrophages, providing a promising therapeutic strategy for acute-on-chronic liver failure.
科研通智能强力驱动
Strongly Powered by AbleSci AI